Brief: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement For Tonmya®, Expanding Total Commercial Coverage To ~52 Million U.S. Lives
08/06/2026 12:10
BRIEF-Tonix Pharmaceuticals Secures Second Commercial Payer Agreement For Tonmya®, Expanding Total Commercial Coverage To ~52 Million U.S. Lives June 8 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O:
TONIX PHARMACEUTICALS SECURES SECOND COMMERCIAL PAYER AGREEMENT FOR TONMYA®, EXPANDING TOTAL COMMERCIAL COVERAGE TO ~52 MILLION U.S. LIVES
Source text: ID:nGNX7xpt80
Further company coverage: TNXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview